Literature DB >> 20430848

Clinical and neuroimaging findings of Cree leukodystrophy: a retrospective case series.

S Harder1, A Gourgaris, E Frangou, K Hopp, R Huntsman, N Lowry, S Seshia, E Lemire, C Robinson, J Tynan.   

Abstract

BACKGROUND AND
PURPOSE: CLD is a rapidly progressive and invariably fatal neurodegenerative disorder. We describe clinical and neuroimaging findings in 5 infants with CLD.
MATERIALS AND METHODS: Retrospective review of medical records of infants with CLD from the past 11 years at our institution was performed. Relevant clinical and demographic data were recorded. Specific attention was directed toward postmortem examination findings and genetic testing. CT and MR imaging results were reviewed.
RESULTS: Five Cree infants were diagnosed with CLD. CT demonstrated bilateral symmetric hypoattenuation of the white matter and globus pallidus. MR imaging demonstrated corresponding T2 hyperintensity in these regions and abnormal signal intensity in the thalami and substantia nigra. Symmetric restricted diffusion in the deep white matter was seen. MRS demonstrated decreased NAA, elevated choline, and the presence of lactate. Postmortem examination in 1 infant showed corresponding poor myelination in the brain stem, cerebellum, deep gray structures, and the cerebral hemispheres. Genetic testing in 2 infants revealed homozygous mutations in the eIF2B5 gene.
CONCLUSIONS: Neuroimaging in CLD is striking and is an important tool in diagnosing CLD. Extensive white matter involvement as well as involvement of the globus pallidus and patchy involvement of the thalami and substantia nigra are characteristic. MRS findings are compatible with destruction of normal brain parenchyma with evidence of anaerobic metabolism in the regions of demyelination. Clinical suspicion of VWM in a Native American infant from this region should prompt the consideration of CLD with appropriate imaging work-up and genetic testing.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20430848      PMCID: PMC7966092          DOI: 10.3174/ajnr.A2108

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  11 in total

1.  eIF2 independently binds two distinct eIF2B subcomplexes that catalyze and regulate guanine-nucleotide exchange.

Authors:  G D Pavitt; K V Ramaiah; S R Kimball; A G Hinnebusch
Journal:  Genes Dev       Date:  1998-02-15       Impact factor: 11.361

Review 2.  Vanishing white matter disease: a review with focus on its genetics.

Authors:  Jan C Pronk; Barbara van Kollenburg; Gert C Scheper; Marjo S van der Knaap
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2006

3.  Cree leukoencephalopathy: neuroimaging findings.

Authors:  I A Alorainy; Y G Patenaude; A M O'Gorman; D N Black; K Meagher-Villemure
Journal:  Radiology       Date:  1999-11       Impact factor: 11.105

4.  Inactivation of eukaryotic initiation factor 2B in vitro by heat shock.

Authors:  G C Scheper; A A Thomas; R van Wijk
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

5.  MRI and CT findings in Krabbe disease.

Authors:  M Sasaki; N Sakuragawa; S Takashima; S Hanaoka; M Arima
Journal:  Pediatr Neurol       Date:  1991 Jul-Aug       Impact factor: 3.372

6.  eIF2B-related disorders: antenatal onset and involvement of multiple organs.

Authors:  Marjo S van der Knaap; Carola G M van Berkel; Jochen Herms; Rudy van Coster; Martina Baethmann; Sakkubai Naidu; Eugen Boltshauser; Michèl A A P Willemsen; Barbara Plecko; Georg F Hoffmann; Christopher G Proud; Gert C Scheper; Jan C Pronk
Journal:  Am J Hum Genet       Date:  2003-10-17       Impact factor: 11.025

7.  Cree leukoencephalopathy and CACH/VWM disease are allelic at the EIF2B5 locus.

Authors:  Anne Fogli; Kondi Wong; Eleonore Eymard-Pierre; Jack Wenger; John-Paul Bouffard; Ehud Goldin; Deborah N Black; Odile Boespflug-Tanguy; Raphael Schiffmann
Journal:  Ann Neurol       Date:  2002-10       Impact factor: 10.422

8.  The effect of genotype on the natural history of eIF2B-related leukodystrophies.

Authors:  A Fogli; R Schiffmann; E Bertini; S Ughetto; P Combes; E Eymard-Pierre; C R Kaneski; M Pineda; M Troncoso; G Uziel; R Surtees; D Pugin; M-P Chaunu; D Rodriguez; O Boespflug-Tanguy
Journal:  Neurology       Date:  2004-05-11       Impact factor: 9.910

9.  Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients.

Authors:  Anne Fogli; Raphael Schiffmann; Lynne Hugendubler; Patricia Combes; Enrico Bertini; Diana Rodriguez; Scot R Kimball; Odile Boespflug-Tanguy
Journal:  Eur J Hum Genet       Date:  2004-07       Impact factor: 4.246

10.  Peripheral neuropathy in a child with Cree leukodystrophy.

Authors:  R J Huntsman; S Seshia; N Lowry; E G Lemire; S L Harder
Journal:  J Child Neurol       Date:  2007-06       Impact factor: 1.987

View more
  1 in total

1.  Modeling vanishing white matter disease with patient-derived induced pluripotent stem cells reveals astrocytic dysfunction.

Authors:  Ling Zhou; Peng Li; Na Chen; Li-Fang Dai; Kai Gao; Yi-Nan Liu; Li Shen; Jing-Min Wang; Yu-Wu Jiang; Ye Wu
Journal:  CNS Neurosci Ther       Date:  2019-02-05       Impact factor: 5.243

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.